banner
Pawg khoom
Tiv tauj peb

Hu rau:Errol Zhou (Mr.)

Tel: ntxiv 86-551-65523315

Mobile/WhatsApp: ntxiv 86 17705606359

QQ:196299583

Skype:lucytoday@hotmail.com

Email:sales@homesunshinepharma.com

Ntxiv:1002, Huanmao Tsev, No.105, Mengcheng Txoj kev, Hefei Lub zos, 230061 Tuam Tshoj

APIs thiab Intermediates
Soquelitinib CAS 2226636-04-8

Soquelitinib CAS 2226636-04-8

CAS Nr .: 2226636-04-8
Cov roj formula: C25H30N4O4S2
Molecular Luj: 514.66
EINECS NO: N / A
MDL NO: N/A

Txhawb tshuaj

Product Description:

Khoom npe: Soquelitinib CAS 2226636-04-8

 

Synonyms:

(R)-N-(5-((5-(4-Acryloyl-3-methyl-1,4-diazepane-1-carbonyl)-4-methoxy-2-methylphenyl)thio)thiazol-2-yl)cyclopropanecarboxamide ;

 

Chemical & Physical Properties:

Cov tsos mob: Dawb rau tawm -dawb hmoov

Assay: Ntau dua lossis sib npaug rau 99.0%

Qhov ceev: 1.34g / cm3

 

 

Kev siv:

Soquelitinib (CPI-818) yog ib qho kev hais lus nquag thiab xaiv covalent interleukin-2-inducing kinase (ITK) inhibitor.

Soquelitinib yog nquag siv nyob rau hauv 6 qhov sib txawv T-cell- kho cov kab mob sib kis thiab kab mob tiv thaiv kab mob, suav nrog mob ntsws asthma thiab mob ntsws, mob ntsws, kab mob sclerosis (scleroderma), psoriasis, thiab mob qog noj ntshav- tiv thaiv - tus kab mob, inhibiting Th2 cytokines.

Soquelitinib txhim kho qog infiltration los ntawm ib txwm CD8+ hlwb nrog T- cuam tshuam kev ua haujlwm.

 

 

Yog tias koj txaus siab rau peb cov khoom lossis muaj lus nug, thov koj xav tiv tauj peb!

 

 

Cov khoom raws li patent yog muab rau R & D lub hom phiaj nkaus xwb. Txawm li cas los xij, lub luag haujlwm kawg tsuas yog nrog tus neeg yuav khoom.

Cim npe nrov: Soquelitinib CAS 2226636-04-8, tuam ntxhab, lwm tus muag khoom, Hoobkas, yuav, hauv Tshuag

Xa kev nug